- Home
- GXAI vs ADIL Comparison
GXAI vs ADIL Comparison
Compare GXAI & ADIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GXAI
- ADIL
- Stock Information
- Founded
- GXAI 2021
- ADIL 2010
- Country
- GXAI United States
- ADIL United States
- Employees
- GXAI N/A
- ADIL N/A
- Industry
- GXAI
- ADIL Biotechnology: Pharmaceutical Preparations
- Sector
- GXAI
- ADIL Health Care
- Exchange
- GXAI Nasdaq
- ADIL Nasdaq
- Market Cap
- GXAI 7.5M
- ADIL 6.5M
- IPO Year
- GXAI 2023
- ADIL 2018
- Fundamental
- Price
- GXAI $2.00
- ADIL $0.96
- Analyst Decision
- GXAI
- ADIL Strong Buy
- Analyst Count
- GXAI 0
- ADIL 1
- Target Price
- GXAI N/A
- ADIL $8.00
- AVG Volume (30 Days)
- GXAI 2.3M
- ADIL 86.8K
- Earning Date
- GXAI 11-14-2024
- ADIL 11-13-2024
- Dividend Yield
- GXAI N/A
- ADIL N/A
- EPS Growth
- GXAI N/A
- ADIL N/A
- EPS
- GXAI N/A
- ADIL N/A
- Revenue
- GXAI $2,979.00
- ADIL N/A
- Revenue This Year
- GXAI N/A
- ADIL N/A
- Revenue Next Year
- GXAI N/A
- ADIL N/A
- P/E Ratio
- GXAI N/A
- ADIL N/A
- Revenue Growth
- GXAI N/A
- ADIL N/A
- 52 Week Low
- GXAI $1.01
- ADIL $0.77
- 52 Week High
- GXAI $19.20
- ADIL $4.17
- Technical
- Relative Strength Index (RSI)
- GXAI 44.91
- ADIL 37.57
- Support Level
- GXAI $1.62
- ADIL $0.99
- Resistance Level
- GXAI $2.03
- ADIL $1.06
- Average True Range (ATR)
- GXAI 0.36
- ADIL 0.06
- MACD
- GXAI -0.13
- ADIL -0.01
- Stochastic Oscillator
- GXAI 20.54
- ADIL 0.00
About GXAI Gaxos.ai Inc.
Gaxos.AI Inc is revolutionizing the way humans interact with artificial intelligence. The company offers applications related to mental and physical well-being, coaching, and gaming. The group is committed to tackling contemporary challenges such as how to live healthier and how to live longer. In addition to offering human-centered solutions, the company uses empathetic and AI technologies.
About ADIL Adial Pharmaceuticals Inc
Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company develops prescription medications for addiction and related disorders. Its lead product is AD04, which is for the treatment of alcohol use disorder. The active ingredient in AD04 is ondansetron, a serotonin-3 antagonist.